This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

INVEGA HAFYERA - Dosage Strengths and Volume of Injection

Last Updated: 04/08/2024

Summary

  • INVEGA HAFYERA is a white to off-white aqueous extended-release injectable suspension for gluteal intramuscular injection in dosage strengths of 1,092 mg/3.5 mL and 1,560 mg/5 mL paliperidone palmitate in single-dose prefilled syringes.1

dosage strengths and VOLUME OF INJECTION

Please see Table: Dosage Strengths and Volume of Injection of INVEGA HAFYERA for specific information relating to the volume of INVEGA HAFYERA in each syringe.1


Dosage Strengths and Volume of Injection of INVEGA HAFYERA1
INVEGA HAFYERA Dosage Strength
Volume of Injection
1,092 mg
3.5 mL
1,560 mg
5 mL

LITERATURE SEARCH

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, DERWENT Drug File (and/or other resources, including internal/external databases) pertaining to this topic was conducted on 28 March 2024.

References

1 Data on File. Paliperidone palmitate 6-month injection. Version 003. Janssen Research & Development, LLC. Paliperidone Palmitate CCDS; 2022.